Breast cancer study using tumor cells in blood
Part of Cancer, Skin clinical trials.
This trial checks whether a blood test that looks at tumor cells can help guide treatment for people with breast cancer. If you join, your care team will follow your responses over time to see if this “phenotype surveillance” approach is useful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 18 years
- Have breast cancer confirmed by pathology (biopsy/surgery report)
- Have no other active cancers and no serious unstable health problems
- Have enough health to expect benefit for at least 6 months (life expectancy >6 months)
- Have normal main organ function (for example, heart/liver/kidney—your doctors will check)
- Be willing to sign consent and follow study follow-up visits; you should be able to cooperate with the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at a blood test that may detect “circulating tumor cells” (cancer cells that can travel in the bloodstream) in people with a specific type of breast cancer. It may help doctors better track the disease and guide treatment for people whose tumors have certain hormone and growth-factor features.
This trial looks at tumor cells in the blood of women with breast cancer to understand them better. It may help doctors learn more about how the disease spreads.
This trial uses a special blood test to track cancer signals (called ctDNA) during and after treatment for early breast cancer. It aims to see whether monitoring these signals can help guide follow-up and treatment decisions.
This study uses blood samples to look for tiny pieces of cancer cells called circulating tumor cells. Your results may help researchers understand how cancer cells spread and how cancer could be monitored over time.
This study measures “circulating tumor markers,” meaning substances from cancer that can show up in blood, to better understand how cancer is doing after treatment. You may join if you recently received cancer care at a participating center and meet basic study and follow-up requirements.
This study compares different methods of capturing circulating tumor cells (CTCs) from blood samples in patients with metastatic breast or prostate cancer. It aims to improve how we detect and monitor cancer cells that have spread, which could help guide future treatment decisions.
Hear when a new Breast Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.